CDK8 Kinase Phosphorylates Transcription Factor STAT1 to Selectively Regulate the Interferon Response  by Bancerek, Joanna et al.
Immunity
ArticleCDK8 Kinase Phosphorylates Transcription Factor
STAT1 to Selectively Regulate the InterferonResponse
Joanna Bancerek,1 Zachary C. Poss,2,5 Iris Steinparzer,1,5 Vitaly Sedlyarov,1 Thadda¨us Pfaffenwimmer,1 Ivana Mikulic,1
Lars Do¨lken,3 Birgit Strobl,4 Mathias Mu¨ller,4 Dylan J. Taatjes,2 and Pavel Kovarik1,*
1Max F. Perutz Laboratories, University of Vienna, Dr. Bohr-Gasse 9, A-1030 Vienna, Austria
2Department of Chemistry and Biochemistry, University of Colorado, Campus Box 596, Boulder, CO 80303, USA
3Department of Medicine, University of Cambridge, Cambridge CB2 0QQ, UK
4Institute of Animal Breeding and Genetics, University of Veterinary Medicine Vienna, A-1210 Vienna, Austria
5These authors contributed equally to this work
*Correspondence: pavel.kovarik@univie.ac.at
http://dx.doi.org/10.1016/j.immuni.2012.10.017Open access under CC BY-NC-ND license.SUMMARY
Gene regulation by cytokine-activated transcription
factors of the signal transducer and activator of tran-
scription (STAT) family requires serine phosphoryla-
tion within the transactivation domain (TAD). STAT1
and STAT3 TAD phosphorylation occurs upon pro-
moter binding by an unknown kinase. Here, we
show that the cyclin-dependent kinase 8 (CDK8)
module of the Mediator complex phosphorylated
regulatory sites within the TADs of STAT1, STAT3,
and STAT5, including S727 within the STAT1 TAD in
the interferon (IFN) signaling pathway. We also
observed a CDK8 requirement for IFN-g-inducible
antiviral responses. Microarray analyses revealed
that CDK8-mediated STAT1 phosphorylation posi-
tively or negatively regulated over 40% of IFN-g-
responsive genes, and RNA polymerase II occu-
pancy correlated with gene expression changes.
This divergent regulation occurred despite similar
CDK8 occupancy at both S727 phosphorylation-
dependent and -independent genes. These data
identify CDK8 as a key regulator of STAT1 and
antiviral responses and suggest a general role for
CDK8 in STAT-mediated transcription. As such,
CDK8 represents a promising target for therapeutic
manipulation of cytokine responses.
INTRODUCTION
The immune system is controlled by cytokine-mediated commu-
nication that is dependent on the Janus kinase (JAK)- signal
transducer and activator of transcription (STAT) signaling
pathway and downstream changes in gene expression (Levy
and Darnell, 2002). Failures in cytokine responses can result
in disorders including immunodeficiency, autoimmunity, or
hematopoietic cancer. The transcription factors of the STAT
family translate cytokine signals into changes in gene expression
patterns. Upon phosphorylation of a tyrosine (around residue
700) by cytokine-receptor-associated JAKs, STAT homodimers250 Immunity 38, 250–262, February 21, 2013 ª2013 Elsevier Inc.or heterodimers translocate to the nucleus, bind DNA, and regu-
late transcription. STATs can be posttranslationally modified on
residues other than tyrosine, and the best characterized is phos-
phorylation of serine in the C-terminal transactivation domain
(TAD), originally described for S727 of STAT1 and STAT3 by
the Darnell laboratory (Wen et al., 1995).
TAD phosphorylation fulfills several independent functions
that are still incompletely understood. TAD phosphorylation
has been most intensively studied in the canonical JAK-STAT
pathway, referred to as the cytokine-elicited signaling cascade,
causing STAT phosphorylation on both tyrosine and serine
(Decker and Kovarik, 2000; Li, 2008). Noncanonical TAD serine
phosphorylation of STATs occurs without concomitant tyrosine
phosphorylation. Most studies, including those of gene-targeted
animals, propose that canonical TAD serine phosphorylation
increases transcriptional activity of STAT1, STAT3, STAT4, and
STAT5 (Friedbichler et al., 2010; Kovarik et al., 2001; Morinobu
et al., 2002; Shen et al., 2004; Varinou et al., 2003; Wen et al.,
1995).
The identity of the kinases responsible for canonical serine
phosphorylation has so far not been sufficiently clarified. We
recently reported that IFN-induced TAD phosphorylation on
S727 of STAT1 occurs only on promoter-bound STAT1 (Sadzak
et al., 2008). Similar results were subsequently reported for
IL-6-induced S727 phosphorylation of STAT3 (Yang et al.,
2010). This chromatin-associated signaling suggests that cyto-
kine-induced TAD serine phosphorylation is accomplished by
components of the general transcription machinery, assembled
at the promoter.
The human Mediator complex acts as a general transcription
factor that is broadly required for the regulation of RNA poly-
merase II (RNAPII) activity and RNAPII-dependent transcription
(Meyer et al., 2010; Taatjes, 2010; Takahashi et al., 2011;
Wang et al., 2005). A four-subunit CDK8 module, consisting of
cyclin-dependent kinase 8 (CDK8), cyclin C (CynC), MED12,
and MED13, reversibly associates with Mediator and regulates
transcription initiation and reinitiation by controlling RNAPII-
Mediator interactions (Elmlund et al., 2006; Knuesel et al.,
2009a). The fundamental importance of CDK8 is reflected in
its requirement for embryonic development in flies and mice
(Loncle et al., 2007; Westerling et al., 2007). The kinase activity
of CDK8 appears essential for its biological function. For
example, CDK8 was identified as a colon cancer oncogene,
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et al., 2008; Morris et al., 2008). Although only a few CDK8
targets have been identified, each, such as transcription factors
and histone H3, can be considered as chromatin associated
(Taatjes, 2010).
Here, we show that CDK8 phosphorylates S727 of the STAT1
TAD in response to IFN-g. In vitro kinase assays and cell-based
gene-silencing experiments demonstrate that CDK8, but not
other chromatin-associated kinases such as CDK7 (TFIIH) or
CDK9 (P-TEFb), is a STAT1 S727 kinase in the canonical IFN-
g-induced signaling pathway. Furthermore, CDK8 phosphory-
lates the TADs of other STAT family members. CDK8 is recruited
to IFN-g-regulated promoters in a STAT1-dependent fashion,
and CDK8 occupancy correlates with STAT1 S727 phosphory-
lation. Microarray analyses indicate that phosphorylation of
STAT1 S727 has different effects at different IFN-g-induced
genes: some genes show decreased expression and others
show increased expression in STAT1 S727A mutant cells.
IFN-g-induced genes that are sensitive to STAT1 S727 phos-
phorylation show altered RNAPII occupancy that correlates
with expression. Interestingly, expression of approximately half
of IFN-g-induced genes is not altered by S727 phosphorylation,
despite evidence for occupancy of S727-phosphorylated
STAT1 at the promoter after IFN-g stimulation. CDK8-silencing
experiments employing transcriptome-wide expression analysis
demonstrate a generally positive role for CDK8 in IFN-g
responses. Cell-based virus-infection experiments reveal a
requirement for CDK8 in IFN-g-mediated establishment of anti-
viral responses, thereby further underlining a fundamental role
for CDK8 in IFN biology. Together, the data show that CDK8
acts to regulate IFN-g responses with gene-selective effects
on STAT1 function. These findings also suggest a general role
for CDK8 in cytokine signaling as a TAD kinase for other STATs.
RESULTS
A Nuclear CDK Mediates Canonical TAD Serine
Phosphorylation of STAT1 and Other STATs
Recent studies by us and others have revealed that cytokine-
induced S727 phosphorylation of STAT1 and STAT3 TADs
is restricted to promoter-bound transcription factors (Sadzak
et al., 2008; Yang et al., 2010). These findings suggest that
TAD phosphorylation is catalyzed by a nuclear kinase in a chro-
matin-associated signaling event. CDK7, CDK8, and CDK9 are
nuclear kinases directly involved in the regulation of transcription
by RNAPII (Egloff and Murphy, 2008). To begin to assess
whether CDK7, CDK8, and/or CDK9 might mediate STAT1
phosphorylation, we probed STAT1 S727 phosphorylation
levels in response to flavopiridol, a CDK inhibitor with increased
specificity for CDK8 and CDK9 (Chao and Price, 2001; Rickert
et al., 1999). Flavopiridol blocked IFN-g- and IFN-b-induced
S727 phosphorylation of STAT1 in murine bone-marrow-derived
macrophages (BMDMs) (Figure 1A). Similar effects were ob-
served in mouse fibroblasts treated with IFNs (Figure S1A,
available online), as well as in human HepG2 cells treated with
IFN-g or IL-6 (Figure 1B), indicating tissue- and organism-
independent involvement of a nuclear CDK. The CDK inhibitors
roscovitine and olomoucine, which inhibit CDK functioning in
the cell cycle (Alessi et al., 1998), did not diminish IFN-inducedS727 phosphorylation (Figure 1C). Importantly, flavopiridol in-
hibited only the canonical (i.e., IFN-induced) S727 phosphory-
lation, shown by the fact that the noncanonical LPS-induced
p38 mitogen-activated protein kinase (MAPK)-driven S727
phosphorylation (Kovarik et al., 1999) was not altered by the
inhibitor (Figure 1D). Similarly, treatment of fibroblasts with the
stress inducer anisomycin resulted in STAT1 S727 phosphory-
lation that was refractory to flavopiridol (Figure S1B). Inhibition
of IFN-g-induced S727 phosphorylation by flavopiridol was
dose dependent (Figure S1C).
Chromatin immunoprecipitation (ChIP) assays confirmed that
flavopiridol-dependent reduction of S727 phosphorylation did
not result from diminished STAT1 promoter binding (Figure S1D).
Flavopiridol is known to globally inhibit transcription by RNAPII
at 300 nM or higher (Chao and Price, 2001). Because we used
flavopiridol at 500 nM, we asked whether a general blockade
of RNAPII-dependent transcription was responsible for the
inhibition of IFN-g-induced phosphorylation. Treatment of cells
with the transcription inhibitor actinomycin D demonstrated
that IFN-g-induced S727 phosphorylation was independent of
ongoing transcription (Figure S1E).
Canonical cytokine-induced serine phosphorylation of STAT1,
STAT3, STAT4, and STAT5 occurs on conserved motifs located
in otherwise divergent TADs (Figure 1E). Phosphorylation of
STAT1 on S727, STAT3 on S727, and STAT4 on S721 occurs
in a PMSP motif (Morinobu et al., 2002; Wen et al., 1995). The
corresponding phosphorylated serines are S725 in STAT5a
and S730 in STAT5b, and both are in a PSP motif (Friedbichler
et al., 2010). The sequence similarities and the requirement for
chromatin binding of both STAT1 and STAT3 in cytokine-
induced TAD phosphorylation suggest that STAT TAD phos-
phorylation might occur by a conserved mechanism.
We examined the role of nuclear CDKs in the canonical
phosphorylation of other STATs by employing flavopiridol.
Flavopiridol inhibited both IFN-b- and IL-10-induced S727
phosphorylation of STAT3 in BMDMs (Figure 1F). Importantly,
only the cytokine-induced (i.e., canonical) S727 phosphorylation
was inhibited by flavopiridol, whereas the LPS-induced MAPK-
driven phosphorylation (Kovarik et al., 2001) remained
unchanged (Figure 1F). Similarly, IL-12- and IFN-b-induced
S721 phosphorylation of STAT4 in splenocytes was sensitive
to flavopiridol (Figure 1G). STAT5 TAD phosphorylation was
assessed by treatment with granulocyte-monocyte colony-
stimulating factor (GM-CSF). GM-CSF-induced S725 phos-
phorylation of STAT5a (and the corresponding S730 in STAT5b)
in BMDMs was inhibited by flavopiridol (Figure 1H), thereby
resembling canonical TAD phosphorylation of other STATs.
Together, these findings reveal that in cytokine-induced
(canonical) responses—conditions causing STAT phosphoryla-
tion on both tyrosine and TAD serine—the STAT TAD serine
kinase(s) is a flavopiridol-sensitive nuclear kinase. Consistently,
noncanonical TAD phosphorylation, which is known to depend
on MAPKs and occurs without concomitant tyrosine phosphor-
ylation, was not impaired by flavopiridol treatment.
CDK8 Phosphorylates S727 in STAT1 TAD in Response
to IFN-g and Is a TAD Kinase of Other STATs
To further characterize the STAT1 TAD kinase, we silenced
genes for the known flavopiridol-sensitive nuclear kinasesImmunity 38, 250–262, February 21, 2013 ª2013 Elsevier Inc. 251
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Figure 1. Canonical Cytokine-Induced TAD
Phosphorylation of STAT1, STAT3, STAT4,
and STAT5 Is Inhibited by Flavopiridol
(A) BMDMs were stimulated for 40 min with IFN-g
or IFN-b after pretreatment or control treatment for
15min with flavopiridol (FP) (500 nM). Cell extracts
were analyzed by immunoblotting with antibodies
against phosphorylated STAT1 at S727 (pS727-
STAT1) or Y701 (pY701-STAT1) and against total
STAT1. Note the presence of two bands detected
by the pY701-STAT1 antibody; they represent
pY701 of STAT1a and STAT1b isoforms, which
are both expressed in BMDMs. STAT1b has Y701
but lacks the TAD (including S727).
(B) Human HepG2 cells were stimulated for
30 min with IFN-g or IL-6 after a 15 min pretreat-
ment with FP. Cell extracts were analyzed as in (A).
(C) BMDMs were stimulated for 40 min with IFN-g
after a 15 min pretreatment with FP, olomoucine
(Olo), or roscovitine (Rosc). Cell extracts were
analyzed as in (A).
(D) BMDMs were stimulated for 40 min with LPS
or IFN-g after a 15 min pretreatment with FP. Cell
extracts were analyzed as in (A).
(E) Sequence alignment of STAT C termini
comprising the TADs of STAT1, STAT3, STAT4,
and STAT5a. The conserved P(M)SP motif con-
taining the serine residue phosphorylated upon
cytokine stimulation is highlighted.
(F) BMDMs were stimulated for 40 min with LPS,
IFN-b, or IL-10 after pretreatment or control
treatment for 15 min with FP. Cell extracts were
immunoprecipitated with antibodies against
STAT3 and were subsequently analyzed by
immunoblotting with antibodies against phos-
phorylated STAT3 at S727 (pS727-STAT3) or Y705
(pY705-STAT3) and against total STAT3.
(G) Mouse splenocytes were stimulated for 40 min
with IL-12 or IFN-b after pretreatment or control
treatment for 15 min with FP. Cell extracts were
analyzedby immunoblottingwithantibodiesagainst
phosphorylated STAT4 at S722 (pS722-STAT4)
or Y694 (pY694-STAT4) and against total STAT4.
(H) BMDMs were stimulated for 40 min with
GM-CSF after pretreatment or control treatment
for 15 min with FP. Cell extracts were analyzed by
immunoblotting with antibodies against STAT5a
phosphorylated at S725 (corresponding to S730
in STAT5b) or Y694 (Y699 in STAT5b) and
against total STAT5.
See also Figure S1.
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CDK8 Regulates STAT1 and Interferon ResponsesCDK7, CDK8, and CDK9 in fibroblasts by using siRNA (Fig-
ure 2A). Silencing of Cdk8, but not Cdk7, resulted in a reduction
of IFN-g-induced STAT1 S727 phosphorylation (Figure 2B).
Silencing of Cdk9 also resulted in a reduction of S727 phos-
phorylation, although it was less pronounced that that of
Cdk8 (Figure 2B and Figure S2A). Compared to silencing of
Cdk8 alone, simultaneous silencing of both Cdk8 and Cdk9
did not result in a further decrease in IFN-g-induced S727
phosphorylation (Figure S2B). Because CDK9 physically and
functionally interacts with the CDK8 module (Donner et al.,
2010; Ebmeier and Taatjes, 2010), decreased S727 phosphor-
ylation in Cdk9-silenced cells might reflect their functional
interdependence.252 Immunity 38, 250–262, February 21, 2013 ª2013 Elsevier Inc.To more definitively assess whether CDK7, CDK8, and/or
CDK9 were phosphorylating STAT1 S727, we completed
a series of in vitro kinase assays. Purified TFIIH (containing
active CDK7), CDK8 module (containing active CDK8), and
P-TEFb (containing active CDK9) were used (Figure S2C).
The kinase substrate included recombinantly expressed wild-
type (WT) or S727A mutant STAT1 TAD. The C-terminal
domain (CTD) of the large subunit of RNAPII was included
as a positive control because all three kinases are each
known to phosphorylate the RNAPII CTD in vitro (Knuesel
et al., 2009b; Wada et al., 1998; Yankulov and Bentley,
1997). The CDK8 module was capable of phosphorylating
WT STAT1 TAD (Figures 2C and 2D), but not the S727A
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Figure 2. CDK8 Phosphorylates S727 of
STAT1 in IFN-g Response
(A) Treatment of mouse fibroblasts with siRNA to
Cdk7, Cdk8, and Cdk9 resulted in the reduction of
the corresponding protein levels. Control siCtrl
(Ctrl) had no effect. Fibroblasts were treated for
48 hr with their respective siRNA, and the protein
amounts of CDK7, CDK8, or CDK9 were subse-
quently detected by immunoblotting. Antibodies
against ERK1 and ERK2 (panERK) were used for
the loading control.
(B) Silencing of Cdk8 reduced IFN-g-induced
STAT1 S727 phosphorylation. Fibroblasts
silenced for the expression of Cdk7, Cdk8, or
Cdk9 were treated for 40 min with IFN-g or were
left untreated. Cell extracts were analyzed by
immunoblotting with antibodies against phos-
phorylated STAT1 at S727 (pS727-STAT1) or Y701
(pY701-STAT1) and against total STAT1.
(C and D) The CDK8 module phosphorylated the
STAT1 TAD in vitro at S727.
(C) Kinase assays using the CDK8 module, TFIIH,
and P-TEFb kinase complexes with STAT1 TAD
(STAT1 WT), STAT1 TAD with the S727A alteration
(STAT1 S727A), or RNAPII C-terminal domain
(Pol II CTD) as substrates. Note that all kinase
substrates have an N-terminal GST tag. The au-
torad image and silver-stained loading reference
are shown for each substrate.
(D) Quantitation of kinase activity for the CDK8
module (CDK8), TFIIH, and P-TEFb against STAT1
WT and STAT1 S727A. All activities were standard-
ized to the CDK8 STAT1 WT autorad signal (100).
Asterisks denote signals that could not be inte-
grated above the background signal; these were
given a relative activity of zero. Shown are represen-
tative data from two independent experiments for
each kinase. All quantitation was done with ImageJ.
(E) Silencing of Cdk8 with siCdk8 (left panel) and
Ccnc with CycC (right panel) resulted in a similar
reduction of IFN-g-induced STAT1 S727 phosphor-
ylation. siCdk8- or siCycC-silenced mouse embry-
onic fibroblasts (MEFs) or control (ctrl)-silenced
cellswere treated for 20or 40minwith IFN-gorwere
left untreated. Cell extracts were analyzed as in (B).
(F) Kinase assays using the CDK8 module, TFIIH, and P-TEFb complexes against substrates STAT3 TAD (S3 WT), S727A STAT3 TAD (S3 S727A), STAT5a TAD
(S5 WT), S725A STAT5a TAD (S5 S725A), S779A STAT5a TAD (S5 S779A), and S725A-S779A STAT5a TAD (S5 S725/S779A). All kinase substrates have an
N-terminal GST tag. The autorad image and silver-stained loading reference are shown for each substrate.
(G) Quantitation of kinase activity (obtained with ImageJ) for the CDK8module against STAT3 and STAT5a TADs and the corresponding mutants described in (F).
The activities were standardized at 100% for STAT3 WT or STAT5a WT. Error bars represent SDs (n = 3).
(H) Silencing of Cdk8 reduced IFN-b-induced STAT3 S727 phosphorylation. Cdk8-silenced fibroblasts were treated for 40 min with IFN-b or were left untreated.
Cell extracts were immunoprecipitated with STAT3 antibodies and analyzed by immunoblotting with antibodies against phosphorylated STAT3 at S727 (pS727-
STAT3) or Y705 (pY701-STAT3) and against total STAT3.
See also Figure S2.
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2C and 2D).
To further assess the role of CDK8 in IFN-g-induced
S727 phosphorylation, we silenced Ccnc, encoding CycC
(Figure S6D), a regulatory subunit of CDK8 (Donner et al.,
2010). Compared with Cdk8-silenced cells, Ccnc-silenced cells
exhibited a similar and, over time, stable reduction of IFN-g-
induced S727 phosphorylation (Figure 2E). Noncanonical
S727 phosphorylation was not influenced by Cdk8 silencing
(Figure S2D). These results indicate a key role for CDK8 in
IFN-g-induced S727 phosphorylation.We next asked whether CDK8 plays a more general role in
JAK-STAT signaling, i.e., by phosphorylating the TADs of other
STATs. First, we employed kinase assays by using recombi-
nantly expressed TADs of WT STAT3, S727A mutant STAT3,
WT STAT5a, S725A mutant STAT5a, S779A mutant STAT5a,
and S725A-S779A double-mutant STAT5a. The STAT5a TAD
contains two serines (S725 and S779) that can be phospho-
rylated in cells, but only S725 is conserved in STAT5a and
STAT5b, whereas S779 occurs only in STAT5a (Friedbichler
et al., 2010). The S725 residue is located in a PSP sequence
that resembles the conserved PMSP motif found in STAT1,Immunity 38, 250–262, February 21, 2013 ª2013 Elsevier Inc. 253
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Figure 3. CDK8 Recruitment to IFN-g Target
Genes Requires STAT1 and Depends on
S727
(A) CDK8 recruitment is dependent on IFN-g (left
panel) and STAT1 (right panel). WT MEFs (left
panel) or WT and Stat1/MEFs (right panel) were
treated with IFN-g, and CDK8 recruitment to the
Irf1 TSS was determined by ChIP. CDK8 was
slowly recruited with peak appearance after
30 min of stimulation (left panel). No increase of
CDK8 was detected at Irf1 in Stat1/ MEFs (right
panel). Immunoprecipitated DNA was analyzed
by qPCR for the Irf1 TSS. Signals were normalized
to input DNA. Error bars represent SDs (n = 3).
(B) STAT1 recruitment (left panel) and slower
increase in S727-phosphorylated STAT1 occu-
pancy at the Irf1 promoter (right panel). WT MEFs
were treated with IFN-g, and STAT1 (left panel) or
S727-phosphorylated STAT1 (right panel) at the
Irf1 promoter was determined by ChIP. Signals
were normalized to input DNA. Error bars repre-
sent SDs (n = 3).
(C) CDK8was recruited to Irf1 (left panel) andGbp2
(right panel); the STAT1 S727A alteration reduced
CDK8 recruitment to both genes. STAT1 WT and
STAT1 S727A MEFs were treated with IFN-g. The
association between CDK8 and the Irf1 and Gbp2
TSSs was examined by ChIP. Signals were
normalized to input DNA. Error bars represent SDs
(n = 3).
(D) The STAT1 WT and the S727A mutant
were similarly recruited to the IFN-g-regulated
promoters. WT and S727A MEFs were treated
for 1 hr with IFN-g or were left untreated. The
association between STAT1 and the Irf1 and
Gbp2 promoters was examined by ChIP. Immu-
noprecipitated DNA was analyzed by qPCR for
the Irf1 and Gbp2 promoters (comprising the
GAS elements). Signals were normalized to input
DNA. Error bars represent SDs (n = 3).
(E) CDK8 was less efficiently recruited by STAT1b
than by STAT1a. MEFs derived from mice ex-
pressing solely STAT1a or STAT1b were treated
with IFN-g. The association between CDK8 and
the Irf1 and Gbp2 TSSs was examined by ChIP as
in (C). Error bars represent SDs (n = 3).
See also Figure S3.
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CDK8 Regulates STAT1 and Interferon ResponsesSTAT3, and STAT4 (Figure 1E), whereas S779 is located within
a distinct LSP motif. The CDK8 module phosphorylated only
the TADs ofWTSTAT3,WTSTAT5a, and S779Amutant STAT5a,
but not those of S727A mutant STAT3, S725A mutant STAT5, or
S725A-S779A double mutant STAT5 (Figures 2F and 2G), indi-
cating that S727 of STAT3 and S725 of STAT5a are CDK8
substrates. TFIIH and P-TEFb did not phosphorylate the
STAT3 or STAT5a TADs (Figure 2F), thereby revealing the
same specific nature of the CDK8-mediated phosphorylation
as observed for the STAT1 TAD (Figures 2C and 2D). Silencing
experiments confirmed CDK8-mediated phosphorylation of
S727 within the STAT3 TAD in vivo (Figure 2H).254 Immunity 38, 250–262, February 21, 2013 ª2013 Elsevier Inc.In summary, these results demonstrate a general role for
CDK8 in phosphorylation of TADs within the STAT family.
Recruitment of CDK8 to IFN-g Target Genes Requires
STAT1 and Depends upon STAT1 S727 Phosphorylation
Our previous finding that IFN-g-induced S727 phosphorylation
occurred only on promoter-bound STAT1 (Sadzak et al., 2008)
prompted us to examine recruitment of CDK8 to the STAT1-
regulated Irf1 promoter. Upon IFN-g treatment, CDK8 gradually
associated with the Irf1 transcription start site (TSS) and peaked
after 30min (Figure 3A, left panel). CDK8 recruitment was STAT1
dependent because the CDK8 signal did not increase in equally
Immunity
CDK8 Regulates STAT1 and Interferon Responsestreated STAT1-deficient cells (Figure 3A, right panel). Further,
CDK8 was not increased 8 kb downstream of the Irf1 TSS (Fig-
ure S3E), consistent with the association between CDK8 and
the promoter-bound Mediator complex. STAT1 recruitment at
Irf1 initiated with a sharp increase 5 min after IFN-g treatment
and peaked at 20 min (Figure 3B, left panel), slightly before
maximal accumulation of CDK8. The IFN-g-induced appearance
of S727-phosphorylated STAT1 at the Irf1 promoter was not
clearly detectable earlier than 20 min after IFN-g stimulation;
thus, it followed promoter recruitment of STAT1 and CDK8
with an approximately 10–15 min delay (Figure 3B, right panel).
These results indicate that STAT1 is required for CDK8
recruitment to Irf1 and further support CDK8 as the STAT1
S727 kinase.
Whereas IFN-g-induced expression of Gbp2 and Tap1 is
sensitive to the STAT1 S727A alteration, expression of Irf1 is
not (Kovarik et al., 2001; Varinou et al., 2003). ChIP assays
demonstrated that S727-phosphorylated STAT1 accumulated
at the Gbp2 and Tap1 promoters (Figures S3A and S3C, right
panels) with a 10–15 min delay after STAT1 recruitment (Figures
S3A and S3C [left panels] and Figures S3B and S3D); this
delay was the same as that observed for the Irf1 promoter (Fig-
ure 3B). The plateau of association between S727-phosphory-
lated STAT1 and chromatin was reached after approximately
60 min of IFN-g treatment (Figure S3F). A similar accumulation
of S727-phosphorylated STAT1 at the S727-sensitive (i.e.,
Gbp2 and Tap1) and -insensitive (i.e., Irf1) promoters established
that the chromatin-associated STAT1 TAD phosphorylation
occurred independently of its downstream effects on transcrip-
tion. These results also indicate that the S727 kinase CDK8
was recruited to both types of genes. To ascertain this, we
compared CDK8 occupancy at the Irf1 and Gbp2 promoters
in mouse embryonic fibroblasts (MEFs) derived from WT and
S727A mice. CDK8 was recruited to both genes, but the
S727A alteration resulted in a decreased CDK8 occupancy
(Figure 3C). Recruitment of the S727A STAT1 mutant was not
lower than that of WT STAT1 at Irf1 or Gbp2, confirming that
the reduced CDK8 recruitment in S727A cells did not result
from altered STAT1 promoter binding (Figure 3D).
To test whether STAT1 fully devoid of the TAD was able to
recruit CDK8, we employed MEFs expressing solely the STAT1a
isoform or the natural splice variant lacking the TAD (STAT1b).
Compared to STAT1a, the STAT1b isoform displayed reduced
CDK8 recruitment (Figure 3E). Similarly, the occupancy of the
Mediator complex (generally needed for CDK8 recruitment
[Elmlund et al., 2006; Knuesel et al., 2009a]) and RNAPII at Irf1
were also reduced in STAT1b cells (Figure S3G). Thus, both
the S727A alteration and the complete lack of the TAD resulted
in diminished CDK8 recruitment.
The STAT1 S727A Alteration Positively or Negatively
Controls Expression of IFN-g-Regulated Genes
The S727A alteration was previously reported to reduce ex-
pression of several IFN target genes (Kovarik et al., 2001; Varinou
et al., 2003), whereas the contribution of CDK8 to IFN-g
responses was unknown. To determine the transcriptome-wide
effect of STAT1 TAD phosphorylation on IFN-g-regulated gene
expression and the role of CDK8 therein, we conducted micro-
array-based analysis by using WT and S727A STAT1 MEFstreated with Cdk8 siRNA (siCdk8) or with control siRNA (siCtrl).
Gene expression was analyzed in MEFs stimulated with IFN-g
for 0 and 4 hr. We first evaluated the effect of S727 phosphory-
lation by examining the microarray data from siCtrl cells. The
analysis of the effect of Cdk8 silencing is described later. Micro-
array data are accessible at theGene ExpressionOmnibus under
accession number GSE40728.
Among 256 genes (p value < 0.05) whose expression was
induced by IFN-g at least 2-fold in WT MEFs (Table S4), we
identified genes that displayed at least 2-fold higher expression
in WT MEFs than in S727A MEFs (Tables S1–S4). Expression
of 61 genes was less induced in S727A MEFs (Figure 4A and
Table S1), expression of 48 genes was higher in S727A MEFs
than in WT MEFs (Figure 4A and Table S2), and expression of
147 genes was not significantly different between S727A cells
and WT cells (Figure 4A and Table S3). The microarray results
were validated by qRT-PCR analysis for a subset of IFN-g-
induced genes (Figure 4B). In total, the absence of IFN-g-
induced S727 phosphorylation resulted in altered expression
of more than 40% of IFN-g-regulated genes. Importantly, the
absence of S727 phosphorylation resulted not only in decreased
expression of some IFN-g-regulated genes but also, unexpect-
edly, increased expression of others.
The so-called primary IFN-g-induced genes depend solely on
STAT1 for their expression, whereas secondary IFN-g-induced
genes require cooperation of STAT1 with additional transcription
factors, particularly IFN regulatory factor (IRF) family members,
which are themselves regulated by IFN (Levy and Darnell,
2002). Primary Irf1, Wars (also known as Ifp-53), and Ifi47 are
each regulated by binding of the STAT1 homodimer to the
IFN-g-activated sequence (GAS) in the promoter (MacMicking
et al., 2003; Pine et al., 1994; Strehlow et al., 1993). These are
the genes whose expression upon IFN-g stimulation was not
significantly affected by the S727A alteration (Tables S3 and
S4). Genes that were less expressed in S727A cells than in WT
cells include Gbp2, Gbp4, Tap1, and Ccl2 (Tables S1 and S4);
each of these genes contains other DNA regulatory elements,
most importantly IFN-stimulated response elements (ISREs), in
addition to GAS elements (Lew et al., 1991; MacMicking,
2004). On the other hand, Irf8 was less expressed in S727A cells
(Figure 4 and Tables S1 and S4), yet its induction by IFN-g was
mediated by a GAS element, but not ISREs (Kantakamalakul
et al., 1999). The group of genes upregulated by IFN-g in
S727A MEFs compared to WT MEFs includes Isg15, Ifi203,
and Ifi204 (Tables S2 and S4). These genes are principally
regulated by ISREs rather than by GAS elements (Kubosaki
et al., 2010; Mamane et al., 2002). As these examples demon-
strate, no good correlation exists between the effects of the
S727A alteration and primary or secondary IFN-g target-gene
expression, although secondary genes appear to be more
sensitive to S727 phosphorylation.
The STAT1 S727A Alteration and the RNAPII
Transcription Rate
To determine whether the STAT1 S727A alteration might
impact the rate of transcription, we measured RNA synthesis
at different time points after stimulation with IFN-g by employ-
ing 4-thiouridine (4sU) metabolic labeling of newly transcribed
RNA (Do¨lken et al., 2008). We added 4sU to the cells eitherImmunity 38, 250–262, February 21, 2013 ª2013 Elsevier Inc. 255
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Figure 4. CDK8-Mediated STAT1 S727
Phosphorylation Is Required for Balanced
Induction of IFN-g-Regulated Genes
(A) Out of 256 IFN-g-induced genes, 61 were less
expressed and 48 were more expressed in the
absence of S727 phosphorylation. WT and S727A
MEFs were stimulated for 4 hr with IFN-g or were
left untreated. mRNA from three biological repli-
cates was analyzed with microarrays. First, genes
significantly (p value < 0.05) induced at least 2-fold
by IFN-g were selected. Expression of these
genes was compared between WT and S727A
cells. At least 2-fold different expression (p value <
0.05) was found for 109 genes, 61 of which dis-
played lower expression and 48 of which higher
expression in S727A cells.
(B) qRT-PCR validation of microarray data. WT
and S727A MEFs were stimulated for 2 and 4 hr
with IFN-g or were left untreated. mRNA of Irf1,
Tap1, Gbp2, Irf8, and Isg15 was analyzed by
qRT-PCR. Irf1 was equally expressed, expression
of Tap1, Gbp2, and Irf8 was reduced, and Isg15
expression was higher in S727A cells. Error bars
display SDs of biological replicates (n = 3).
See also Tables S1–S4.
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tion or without IFN-g treatment. The metabolic labeling was
performed for 30 min. Given that the mRNA half-lives were
higher than the 30 min labeling interval (Figure S4A), the
amount of labeled RNA was proportional to the RNA tran-
scribed during each interval. The 4sU-labeled RNA fraction
was separated from total RNA. Aliquots of total RNA were
saved before separation. The amount of total mRNA of Irf1,
Tap1, Gbp2, Irf8, and Isg15 (Figure S4B) was similar to mRNA
levels determined in a standard experiment (i.e., no 4sU) (Fig-
ure 4B), demonstrating the consistency of both methods.
Analysis of the labeled fractions revealed that the rate of
mRNA synthesis in the 30 min labeling periods (Figure 5)256 Immunity 38, 250–262, February 21, 2013 ª2013 Elsevier Inc.reflected the amount of total mRNA in
both WT and S727A cells (Figure S4B)
for all analyzed genes except for Irf1.
The amount of labeled Irf1 mRNA was
reduced by approximately one-third in
S727A cells compared to WT cells.
Such differences were not reflected in
total RNA measurements as a result of
permanent mRNA turnover. Primary
transcript measurements confirmed that
the effects of the S727A alteration re-
sulted from changes in transcription
(Figure S4C). These data demonstrate
a gene-selective role for STAT1 S727
phosphorylation in controlling the tran-
scription rate.
Gene-Selective Role of STAT1 S727
Phosphorylation on RNAPII
To better understand the gene-specific
role of CDK8-mediated STAT1 S727phosphorylation on the transcription of IFN-g-induced genes,
we selected Irf1, a GAS-driven IFN-g target gene, as well as
the GAS- and ISRE-controlled IFN-g target genes Gbp2 and
Tap1, for detailed analysis (Figure S5A). We examined the
recruitment of RNAPII at the TSSs of Irf1, Gbp2, and Tap1 in
WT and S727A MEFs. RNAPII was recruited to the Irf1 TSS
equally well in IFN-g-treated WT and S727A cells (Figure 6A,
left panel). By contrast, occupancy of RNAPII at the Tap1 and
Gbp2 TSSs was lower in S727A cells than in WT controls
(Figure 6A, middle and right panels). These data are in
agreement with the diminished IFN-g-induced expression of
Gbp2 and Tap1 but unchanged Irf1 expression in S727A MEFs
(Figure 4B).
Figure 5. Detection of IFN-g-Induced Gene
Expression in WT and S727A Cells by
Analysis of Newly Transcribed RNA
4sU was added to the cell-culture medium simul-
taneously with IFN-g, 60 and 210 min after IFN-g
stimulation, or without IFN-g treatment. Labeling
was performed in WT and S727A MEFs for 30 min
and was followed by RNA isolation and separation
for the collection of the 4sU-labeled RNA fractions
and total RNA fractions. The labeled RNA fractions
represented RNA that was synthesized during
a 30 min interval before stimulation of cells, as
well as in the periods 0–30 min, 60–90 min, and
210–240 min after IFN-g treatment. The amount of
Irf1, Tap1, Gbp2, Irf8, and Isg15 mRNA was
measured in the labeled (i.e., newly synthesized)
fractions by qRT-PCR. ActB was used for
normalization. Error bars represent SDs (n = 3).
See also Figure S4.
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normalization to total RNAPII) in the gene bodies of transcribed
genes provides a robust estimate of transcription elongation.
We analyzed the presence of RNAPII and S2-phosphorylated
RNAPII at the gene bodies of Irf1 (intron 8) and Tap1 (intron 5),
i.e., at positions approximately 5.6 kb and 4.2 kb, respectively,
downstream of their respective TSSs (Figure S5A). RNAPII was
present at comparable amounts in WT and S727A cells, and
S2-phosphorylated RNAPII was slightly reduced by the S727A
alteration (Figure 6B). After normalization to total RNAPII, the
reduction of S2-phosphorylated RNAPII in the Irf1 gene body
in S727A cells became more apparent (Figure 6B, right panel),
which is in line with the slower rate of RNA synthesis detected
by 4sU labeling (Figure 5A). In the case of Tap1, both RNAPII
and S2-phosphorylated RNAPII associated with the gene body
in S727A cells to a much lesser extent than in WT cells (Fig-
ure 6C). The lower abundance of S2-phosphorylated RNAPII
within Tap1 remained pronounced in the S727A cells after
normalization to the total RNAPII (Figure 6C, right panel). The
data are consistent with the strong effect of S727 phosphory-
lation on Tap1 mRNA levels and the lack of such an effect in
the case of Irf1. As expected, comparison of the ratios of S2-
phosphorylated RNAPII to total RNAPII showed lower relative
occupancy of S2-phosphorylated RNAPII at the TSS relative to
the gene body for both Irf1 and Tap1 (Figure S5B). Collectively,
these data demonstrate that despite general recruitment of
CDK8 and the subsequent presence of S727-phosphorylated
STAT1 at IFN-g target promoters, the precise downstream
effects on RNAPII recruitment and RNAPII phosphorylation are
gene specific.Immunity 38, 250–262,CDK8 Is a Broad Regulator of IFN-g-
Induced Gene Expression and Is
Required for Antiviral Response
CDK8 can positively or negatively
impinge on transcription by acting as
both a kinase and a structural component
within the Mediator complex (Taatjes,
2010). To further confirm the role of
CDK8 in controlling IFN-g responses viaSTAT1 S727 phosphorylation, we silenced Cdk8 expression
and compared IFN-g-induced gene expression in STAT1 WT
and S727A cells by using microarrays. Cells were treated
with siCdk8 or siCtrl and were subsequently stimulated with
IFN-g for 4 hr. Silencing efficiency was approximately 90% in
both WT and S727A cells (Figure S6A). Importantly, the siRNA
transfection procedure did not itself result in any changes
in Cdk8 expression (Figure S6B). IFN-g-induced gene expres-
sion profiles revealed that in STAT1 WT cells, Cdk8 silencing
resulted in downregulation of 69% of IFN-g-stimulated genes
(Figure 7A and Table S4, column 8). Similar effects were
observed in STAT1 S727A cells (Figure 7B and Table S4,
column 9). As expected, the microarray experiment identified
IFN-g-induced gene expression changes shared by S727A
cells and Cdk8-silenced cells (Figure 7C and Table S5). The
overlap, which represents 55% of all S727-regulated genes
and includes Tap1, Gbp2, and Irf8, contained 60 genes, of
which 43 were downregulated and 17 were upregulated
(Table S5).
Validation of the microarray data (Figure S6C) confirmed that
the physical presence of CDK8 was generally required for full
expression of both STAT1-S727-phosphorylation-dependent
(Tap1,Gbp2, and Irf8) and -independent (Irf1) genes (Figure 7D).
The STAT1-TAD-phosphorylation-independent contribution
of CDK8 to IFN-g-induced gene expression was gene specific
(Figure 7D, right panel). Ccnc silencing reproduced the Cdk8-
silencing experiment, although the differences were slightly
bigger for Ccnc siRNA (siCycC) than for siCdk8 (Figure 7E).
This is likely due to a reproducibly higher silencing efficiency ob-
tained for Ccnc (98%) than for Cdk8 (Figures S6A and S6D).February 21, 2013 ª2013 Elsevier Inc. 257
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Figure 6. STAT1 S727 Phosphorylation
Controls Chromatin Recruitment of RNAPII
and S2-Phosphorylated RNAPII in a Gene-
Specific Manner
(A) Association between RNAPII and the TSSs of
Irf1, Tap1, and Gbp2 in WT and S727A MEFs
treated for 1 and 2 hr with IFN-g was examined by
ChIP with RNAPII antibodies. Immunoprecipitated
DNAwas analyzed by qPCR for the Irf1,Gbp2, and
Tap1 TSSs. Signals were normalized to input DNA.
Error bars represent SDs (n = 3).
(B and C) Association between RNAPII and S2-
phosphorylated RNAPII and the gene body (intron
8) of Irf1 (B) and the gene body (intron 5) of Tap1 (C)
in WT and S727A MEFs treated for 1 and 2 hr with
IFN-g was examined by ChIP with antibodies
against RNAPII (left panels) and pS2-RNAPII
(middle panels). Immunoprecipitated DNA was
analyzed by qPCR for Irf1 intron 8 and Tap1 intron
5. Signals were normalized to input DNA. Error
bars represent SDs (n = 3). Right panels depict the
ratios of pS2-RNAPII to total RNAPII.
See also Figure S5.
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expression of Cdk8 (Figure S6B).
The broad effect of CDK8 on IFN-g-induced gene expression
prompted us to test the biological role of the CDK8 module
in IFN-g responses by using vesicular stomatitis virus (VSV)
infection. We infected siCycC- and siCtrl-silenced cells pre-
treated with serial dilutions of IFN-g. Because of a better
silencing efficiency, Ccnc, rather than Cdk8, was chosen
(Figures S6A and S6D). Ccnc silencing resulted in higher sensi-
tivity to VSV and 10-fold higher IFN-g requirement for efficient
protection against VSV (Figure 7F). Control experiments demon-
strated no effect of siRNA transfection on the sensitivity to VSV
(Figure S6E). These findings establish that CDK8 function is
required for IFN-g-inducible antiviral responses.
DISCUSSION
The identity of the chromatin-associated kinase that targets
STAT1 S727 has long remained unknown; in this study, we es-
tablished CDK8 as a STAT1 S727 kinase and a key component
of the IFN-g signaling pathway. Remarkably, CDK8-dependent
STAT1 S727 phosphorylation was stimulus specific and
restricted to canonical IFN-g signaling, evident by the fact that
noncytokine stimuli (e.g., LPS or anisomycin) were not sensitive
to CDK8. CDK8 involvement in IFN-g signaling resulted in
downstream effects on transcription. These effects were gene
specific; some genes were upregulated, and others were
downregulated, providing an additional layer of control and
modulation of IFN-g-regulated gene expression. Indeed, these
varied and selective CDK8 inputs appear to be required for the
establishment of a functional antiviral response.258 Immunity 38, 250–262, February 21, 2013 ª2013 Elsevier Inc.Our study established that CDK8-
mediated STAT1 S727 phosphorylation
regulates the expression of over 40% of
IFN-g-induced genes in MEFs. Surpris-
ingly, the IFN-g-induced gene expressionwas both positively and negatively modulated by STAT1 S727
phosphorylation. Expression of Irf1, Wars, and Ifi47, regulated
primarily by STAT1 binding to GAS elements, was not sensitive
to S727 phosphorylation. By employing metabolic labeling of
newly transcribed RNA, however, we observed subtle effects
of S727 phosphorylation on the rate of Irf1 transcription, sug-
gesting that the impact of S727 phosphorylation on transcription
does not exclude GAS-driven genes. This is further supported
by the markedly reduced expression of the GAS-controlled
Irf8 in the absence of S727 phosphorylation. Gbp2, Gbp4,
Tap1, and Ccl2, which require STAT1 and IRF1 and depend
on GASs and ISREs, needed S727 phosphorylation for full
IFN-g-induced expression. This, however, did not allow ageneral
conclusion with regard to regulation by S727 phosphorylation
given that Gbp5, which also contains ISREs and GAS elements
(Nguyen et al., 2002), was not affected by the S727A alteration.
Finally, genes primarily regulated by ISREs also displayed
variable sensitivity to the S727A alteration; for example, expres-
sion of Isg15 was upregulated, whereas Oas1 expression was
unchanged.
Collectively, the gene expression data reveal no direct correla-
tion between the effects of STAT1 S727 phosphorylation and
gene regulation by GASs, ISREs, or both DNA elements. This
most likely reflects the presence of gene-specific coactivators
or corepressors that differentially rely on STAT1 S727 phospho-
rylation for their recruitment and/or activity. One candidate-
gene-selective coregulator is the Mediator complex, whose
activity is regulated in various ways upon transcription factor
binding (Ebmeier and Taatjes, 2010; Taatjes, 2010). The CDK8
module reversibly associates with Mediator on a genome-wide
scale (Kagey et al., 2010; Knuesel et al., 2009a), and Mediator
A B C
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Figure 7. The CDK8 Module Regulates
Most IFN-g-Induced Genes and Impairs
Antiviral Response
(A and B) Most IFN-g-induced genes were
downregulated by Cdk8 silencing in both STAT1
WT and S727A cells. STAT1 WT (A) or S727A (B)
MEFs were treated with siCdk8 or siCtrl and
were stimulated for 4 hr with IFN-g or were
left untreated. mRNA from three biological repli-
cates was analyzed with microarrays. Out of 256
IFN-g-induced genes, 177 (69%) were less ex-
pressed in WT STAT1 cells treated with siCdk8
than in siCtrl treated cells (A). In STAT1 S727A
cells, 162 genes (63%) were less expressed by
siCdk8 (B). The numbers were extracted from
Table S4.
(C) Overlap of genes similarly regulated by
S727 phosphorylation and CDK8. The left circle
shows IFN-g-induced genes that were signifi-
cantly changed (upregulated or downregulated) in
S727A cells. The right circle shows IFN-g-induced
genes that changed (upregulated or down-
regulated) upon Cdk8 silencing in WT cells. The
overlap depicts genes (60 in total) that were
either downregulated or upregulated by both
the S727A alteration and Cdk8 silencing. The
numbers were extracted from Table S4.
(D) Validation of microarray data. WT or S727A
MEFs treated with siCdk8 or siCtrl were
stimulated for 4 hr with IFN-g or were left un-
stimulated, and mRNA for Irf1, Tap1, Gbp2,
and Irf8 was analyzed by qRT-PCR. For each
gene, mRNA was normalized to Hprt mRNA
and standardized to 1.0 for the siCtrl-treated
samples. Error bars display SDs of biological
replicates (n = 3).
(E) The effect of Ccnc silencing (with siCycC) on
IFN-g-regulated genes was similar to that of Cdk8
silencing. WT or S727A MEFs treated with siCycC
or siCtrl were stimulated for 4 hr with IFN-g or
were left unstimulated. mRNA for Irf1, Tap1,
Gbp2, and Irf8 was analyzed by qRT-PCR. For
each gene, mRNA was normalized to Hprt mRNA
and standardized to 1.0 for the siCtrl-treated
samples. Error bars represent SDs (n = 3).
(F) Silencing of Ccnc with siCycC resulted in
increased sensitivity of cells to VSV infection.
STAT1 WT cells were treated with siCycC or siCtrl
and were incubated with IFN-g at the indicated
concentrations. After 24 hr of IFN-g treatment, cells were infected with vesicular stomatitis virus (VSV) (multiplicity of infection = 0.1) for 39 hr. Cell survival
was then evaluated with crystal-violet staining. Mean crystal-violet values of duplicate experiments are shown.
See also Figure S6 and Table S5.
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scription factors. We observed a correlation between STAT1
S727 phosphorylation and CDK8 occupancy at IFN-g-regulated
genes. In fact, the effects of complete loss of the STAT1 TAD
on CDK8 recruitment were similar to those of the S727A
alteration. The dependence of CDK8 occupancy on STAT1
phosphorylation parallels the ELK-1 transcription factor, for
which stimulus-specific ELK-1 phosphorylation enhanced
Mediator occupancy at its target genes (Balamotis et al.,
2009). Future studies could explore the mechanisms by which
CDK8-dependent STAT1 phosphorylation regulates Mediator
or other gene-specific coregulators at select target genes.Consistent with its role as both a general and gene-selective
regulator of transcription, CDK8 can regulate IFN-g responses
independently of STAT1 S727 phosphorylation. This was
evident from comparative gene expression analyses, in which
we observed significant, but not complete, overlap among genes
impacted by Cdk8 silencing versus the STAT1 S727A alteration.
Such results were not unexpected given the stark difference
between physical loss of CDK8 and modification of a single
CDK8 substrate (STAT1 S727). A total of 60 genes (55% of
all STAT1-S727-regulated genes) were similarly impacted by
Cdk8 silencing and the STAT1 S727A alteration. These genes
are most likely directly regulated by the S727-targeted CDK8Immunity 38, 250–262, February 21, 2013 ª2013 Elsevier Inc. 259
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silencing and STAT1-S727A experiments probably depend on
the physical presence of CDK8 or require CDK8 to act upon
substrates other than STAT1 for normal IFN-g-induced expres-
sion. Moreover, at least some genes differentially affected in
Cdk8-silenced cells will result from indirect effects of CDK8
(e.g., elevated expression of a gene-selective STAT1 core-
pressor). A small number of S727A-regulated genes (15 in total)
appeared unaltered by Cdk8 silencing. It remains possible that
a distinct kinase, perhaps even the CDK8 paralog CDK19, might
be acting at these genes.
STAT1 adds to the growing number of CDK8 substrates in
Metazoa; these include CDK8 itself, cyclin H, MED13, histone
H3, and the transcription factors E2F1, Notch, SMAD1/
SMAD3, and SREBP (Akoulitchev et al., 2000; Alarco´n et al.,
2009; Fryer et al., 2004; Knuesel et al., 2009b; Meyer et al.,
2008; Morris et al., 2008; Zhao et al., 2012). Phosphorylation of
SREBP or Notch by CDK8 and phosphorylation of Smads by
CDK8 and/or CDK9 result in an increased turnover of these
factors as a result of proteolytic degradation (Alarco´n et al.,
2009; Fryer et al., 2004; Zhao et al., 2012). STAT1 is not regulated
in this way given that we observed that inhibition of S727
phosphorylation by flavopiridol or by the S727A alteration did
not change the amount of promoter-bound STAT1.
STAT1 is phosphorylated byCDK8 at a serine residue followed
by proline, thereby resembling the proline-directed serine phos-
phorylation of SMAD1, SMAD3, and the RNAPII CTD (Alarco´n
et al., 2009; Fryer et al., 2004; Knuesel et al., 2009b). Phosphor-
ylation of cyclin H and histone H3 does not occur in a proline-
directed fashion, suggesting relaxed substrate specificity of
CDK8 toward proteins other than transcription factors (Akou-
litchev et al., 2000; Meyer et al., 2008). The conserved PMSP
sequence motif at the serine-phosphorylated sites within
different STAT TADs suggests that a single kinase might phos-
phorylate multiple STATs. The shared sensitivity of STAT1,
STAT3, STAT4, and STAT5 TAD phosphorylation to inhibition
by flavopiridol and the ability of the CDK8 module to phosphor-
ylate STAT1, STAT3, and STAT5 TADs demonstrate a general
role for CDK8 in STAT TAD phosphorylation and suggest that
CDK8 regulates the transcriptional activity of other STATs in
a similar way as established here for STAT1.
Given the fundamental roles for STAT transcription factors in
human growth and development, immune response, and cancer
(Levy and Darnell, 2002), this work also identifies CDK8 as a
therapeutic target within the STAT pathway. Diminished CDK8
function resulted in an impaired antiviral response, establishing
a general requirement for CDK8 in IFN-g responses. The ability
of the CDK8 module—but not other chromatin-associated
kinase complexes such as P-TEFb or TFIIH—to phosphorylate
important regulatory sites within the STAT transcription factor
family suggests a conserved role in regulating STAT activity
during cytokine responses. Similar to our observations with
STAT1, CDK8 has been shown to differentially regulate expres-
sion of subsets of genes within the serum response and WNT/
b-catenin pathways (Donner et al., 2010; Firestein et al., 2008).
In SREBP-regulated lipogenesis, CDK8 acts as a negative
regulator (Zhao et al., 2012). Thus, despite being a cofactor of
the general transcription machinery, CDK8 emerges as a sur-
prisingly pathway-specific regulator of transcriptional networks.260 Immunity 38, 250–262, February 21, 2013 ª2013 Elsevier Inc.CDK8 requirement in cellular protection against viral infection
suggests that CDK8-associated defects might contribute to
immune disorders. Our work highlights a central role for CDK8
in STAT-dependent cytokine responses and its increasingly
recognized suitability for therapeutic exploitation.
EXPERIMENTAL PROCEDURES
Cell Culture
Primary MEFs were isolated from mice expressing WT STAT1 or the S727A
mutant (Varinou et al., 2003) (both on C57BL/6N) and were immortalized via
the 3T3 method (Todaro and Green, 1963) for the attainment of STAT1 WT
and STAT1 S727A MEFs, respectively. STAT1 WT and STAT1 S727A MEFs,
MEFs from Stat1/ mice (Durbin et al., 1996) and human hepatocarcinoma
HepG2 cells (ATCC number HB-8065) were grown in Dulbecco’s modified
Eagle’s medium (DMEM) supplemented with 10% fetal calf serum (FCS).
Mouse BMDMs were isolated from the femur and tibia bone marrow of 6- to
10-week-old C57BL/6Nmice. Macrophages were cultivated in DMEM supple-
mented with 10% FCS in the presence of L929-cell-derived CSF-1 as previ-
ously described (Kovarik et al., 1998). Mouse splenic cells were isolated
from spleens of 6- to 10-week-old C57BL/6N mice. Spleens were removed
and squeezed through a 100 mm cell strainer. The single-cell suspension
was than treated with red blood cell lysis buffer. The cells were expanded
for 3–5 days in medium composed of RPMI-1640 containing L-glutamine
and supplemented with 10% FCS, 50 mM 2-mercaptoethanol, 1 mM sodium
pyruvate, nonessential amino acids, 100 U/ml penicillin, 100 mg/ml strepto-
mycin, and 100 U/ml IL-2 (all Sigma-Aldrich).
Cytokines and Inhibitors
For stimulations of cells, the following reagents were used: 5 or 10 ng/ml
mouse IFN-g (eBioscience), 100 U/ml mouse IFN-b (Calbiochem-Merck),
100 ng/ml anisomycin (Sigma-Aldrich), 10 ng/ml LPS from E. coli (Sigma-
Aldrich), 10 ng/ml mouse IL-10 (eBioscience), 10 ng/ml mouse IL-6 (R&D
Systems), 10 ng/ml mouse IL-12 (R&D Systems), X-6310-cell-derived
GM-CSF as 1:2 dilution in DMEM with 10% FCS, 10 ng/ml human IFN-g
(R&D Systems), and 10 nM human IL-6 (R6D Systems). Flavopiridol was ob-
tained through the National Institutes of Health (NIH) AIDS Research and
Reference Reagent Program, Division of AIDS, NIH National Institute of Allergy
and Infectious Diseases and was used in a final concentration of 500 nM if not
stated otherwise. Roscovitine and olomoucin (both Calbiochem-Merck) were
used in a concentration of 50 mM, and 5 mg/ml actinomycin D (Sigma-Aldrich)
was used.
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